Fig 5. Characteristics of good and non responders in early RA.
CRP-concentrations (A), the activating:inhibiting FcR expression ratio (B), and the monocyte CD32b expression (C) in good (n = 7) versus non responders (n = 8) before and after treatment with methotrexate and prednisolone in early RA. (the activating:inhibiting FcR expression ratio was defined as the ratio of the sum of the MFIs of the activating CD64 + CD32a + CD16a divided by the MFI of the inhibiting CD32b).